NKG2D ligand recognition pathway

The NKG2D ligand recognition pathway is an immune surveillance mechanism in which the activating receptor NKG2D (expressed on NK cells, CD8+ T cells, γδ T cells, and certain macrophages) binds to stress-induced self-ligands (such as MICA, MICB, and ULBP1-6 in humans) that are upregulated on the surface of infected, transformed (malignant), damaged, or senescent cells. This interaction leads to activation of cytotoxic immune responses aimed at eliminating the abnormal cells. The pathway is highly regulated at transcriptional, translational, and posttranslational levels, as both viral pathogens and tumors may evolve strategies to evade recognition by disrupting ligand expression or function. While the NKG2D receptor or its ligands are studied as therapeutic targets in immuno-oncology and infectious diseases, the pathway as a whole is a biological mechanism rather than a discrete drug target. If the intention was to retrieve structured data for a therapeutic target, it would be advisable to focus specifically on "NKG2D receptor (KLRK1)" or individual ligands such as "MHC class I polypeptide-related sequence A (MICA)" or "UL16-binding protein 2 (ULBP2)". The current entry, as phrased, refers to a recognition pathway, not a singular molecular entity.

Other names

NKG2D–ligand axisNKG2D receptor–ligand systemNKG2D recognition axis

Enhancing immune recognition via NKG2D ligand upregulation; Blocking immune evasion by preventing cleavage/shedding of ligands; Antibody therapy to engage or block receptor-ligand interaction.